Introduction
Materials and methods
Immunohistochemistry (IHC)
Scoring of IHC
In vitro study
Reverse phase protein microarray (RPPA)
Statistical analysis
Results
MAPK expression in BC tissue
The association between MAPKs and clinicopathological variables
Pan ERK1/2 | Nuclear p-ERK1/2 | Cytoplasmic-p-ERK1/2 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
Grade | |||||||||
1 | 85 (14) | 99 (17) |
0.031
| 54 (9) | 118 (20) |
<0.0001
| 52 (10) | 119 (20) |
0.001
|
2 | 199 (32) | 203 (36) | 156 (28) | 241 (41) | 172 (32) | 220 (36) | |||
3 | 338 (54) | 268 (47) | 352 (63) | 235 (39) | 310 (58) | 271 (44) | |||
Lymph node stage | |||||||||
1 | 379 (61) | 343 (60) | 0.085 | 343 (61) | 118 (20) | NS | 313 (58) | 384 (63) | NS |
2 | 180 (29) | 188 (33) | 170 (30) | 241 (41) | 164 (31) | 178 (29) | |||
3 | 63 (10) | 40 (7) | 49 (9) | 235 (39) | 57 (11) | 48 (8) | |||
Tumour size | |||||||||
<2 CM | 290 (47) | 301 (53) |
0.029
| 242 (43) | 324 (54) |
<0.0001
| 222 (42) | 336 (55) |
<0.0001
|
>2CM | 334 (53) | 269 (47) | 321 (57) | 272 (46) | 312 (58) | 277 (45) | |||
Lymphovascular invasion | |||||||||
No | 399 (65) | 381 (67) | 357 (64) | 399 (67) | 322 (61) | 425 (70) |
0.001
| ||
Definite | 219 (35) | 190 (33) | NS | 202 (36) | 192 (33) | NS | 210 (39) | 181(30) | |
NPI | |||||||||
GPG | 170 (28) | 183 (34) |
0.015
| 121 (23) | 209 (37) |
<0.0001
| 122 (24) | 205 (35) |
<0.0001
|
MPG | 324 (54) | 293 (54) | 314 (59) | 293 (51) | 286 (56) | 317 (54) | |||
PPG | 106 (18) | 66 (12) | 101 (19) | 70 (12) | 104 (20) | 64 (11) |
Pan JNK1/2 | p-JNK1/2 | Pan p38 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
Grade | |||||||||
1 | 100 (17) | 104 (19) | NS | 26 (11) | 131 (16) |
<0.0001
| 26 (11) | 131 (16) |
0.002
|
2 | 216 (36) | 168 (32) | 45 (20) | 308 (37) | 45 (20) | 308 (37) | |||
3 | 277 (47) | 260 (49) | 156 (69) | 388 (50) | 156 (69) | 388 (50) | |||
Lymph node stage | |||||||||
1 | 398 (65) | 356 (65) | NS | 140 (62) | 498 (60) | NS | 140 (62) | 498 (60) | NS |
2 | 169 (8) | 150 (27) | 66 (29) | 260 (32) | 66 (29) | 260 (32) | |||
3 | 46 (7) | 42 (8) | 21 (9) | 69 (8) | 21 (9) | 69 (8) | |||
Tumour size | |||||||||
<2 CM | 283 (50) | 274 (55) | 0.079 | 93 (40) | 427 (52) |
0.003
| 93 (40) | 427 (52) | NS |
>2 CM | 286 (50) | 223 (45) | 137 (60) | 401 (48) | 137 (60) | 401 (48) | |||
Lymphovascular invasion | |||||||||
No | 376 (67) | 344 (69) | NS | 153 (67) | 540 (66) | NS | 153 (67) | 540 (66) | NS |
Definite | 187 (33) | 152 (31) | 76 (33) | 282 (34) | 76 (33) | 282 (34) | |||
NPI | |||||||||
GPG | 192 (33) | 181 (35) | NS | 47 (21) | 255 (32) |
0.002
| 47 (21) | 255 (32) |
0.013
|
MPG | 303 (53) | 266 (52) | 132 (60) | 435 (55) | 132 (60) | 435 (55) | |||
PPG | 79 (14) | 69 (13) | 42 (19) | 103 (13) | 42 (19) | 103 (13) |
p-p38 | p–C-JUN | p-ATF2 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
Grade | |||||||||
1 | 120 (13) | 82 (21) |
<0.0001
| 62 (14) | 135 (16) |
<0.0001
| 114 (12) | 81 (24) |
<0.0001
|
2 | 293 (31) | 166 (43) | 119 (26) | 313 (38) | 303 (32) | 139 (42) | |||
3 | 525 (56) | 142 (36) | 268 (60) | 380 (46) | 539 (56) | 114 (34) | |||
Lymph node stage | |||||||||
1 | 550 (59) | 261 (67) |
0.008
| 266 (59) | 517 (62) | NS | 571 (60) | 208 (62) | NS |
2 | 310 (33) | 96 (24) | 143 (32) | 251 (30) | 311 (32) | 92 (28) | |||
3 | 78 (8) | 34 (9) | 40 (9) | 61 (8) | 74 (8) | 35 (10) | |||
Tumour size | |||||||||
<2 CM | 423 (45) | 225 (58) |
<0.0001
| 206 (46) | 421 (51) | 0.080 | 451 (47) | 173 (52) | NS |
>2 CM | 517 (55) | 166 (42) | 245 (54) | 408 (49) | 507 (53) | 162 (48) | |||
Lymphovascular invasion | |||||||||
No | 602 (65) | 284 (73) |
0.002
| 278 (62) | 566 (69) |
0.015
| 611 (64) | 234 (71) |
0.032
|
Definite | 332 (35) | 104 (27) | 171 (38) | 258 (31) | 344 (36) | 98 (29) | |||
NPI | |||||||||
GPG | 235 (26) | 159 (43) |
<0.0001
| 114 (26) | 264 (33) |
0.001
| 240 (26) | 132 (41) |
<0.0001
|
MPG | 508 (57) | 177 (47) | 238 (55) | 426 (54) | 530 (58) | 143 (45) | |||
PPG | 156 (17) | 38 (10) | 84 (19) | 100 (13) | 149 (16) | 44 (14) |
The association between MAPKs and key BC biomarkers
Pan ERK1/2 | Nuclear p-ERK1/2 | Cytoplasmic-p-ERK1/2 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
ER | |||||||||
Negative | 176 (28) | 112 (20) |
<0.0001
| 186 (33) | 102 (17) |
<0.0001
| 146 (28) | 139 (23) |
0.066
|
Positive | 444 (72) | 460 (80) | 373 (67) | 487 (83) | 385 (72) | 468 (77) | |||
HER2 | |||||||||
Negative | 516 (87) | 480 (87) | NS | 443 (83) | 516 (90) |
<0.0001
| 442 (86) | 506 (86) | NS |
Positive | 75 (13) | 70 (13) | 93 (17) | 58 (10) | 71 (14) | 79 (14) | |||
KI67-LI | |||||||||
Low | 200 (39) | 208 (46) | 0.050 | 153 (34) | 224 (47) |
<0.0001
| 159 (37) | 233 (47) |
0.003
|
High | 307 (61) | 247 (54) | 304 (66) | 250 (53) | 266 (63) | 263 (53) | |||
P53 | |||||||||
Negative | 400 (68) | 405 (73) | 0.064 | 361 (68) | 416 (74) |
0.032
| 351 (69) | 416 (72) | NS |
Positive | 185 (32) | 147 (27) | 172 (32) | 149 (26) | 160 (31) | 158 (28) | |||
BCL2 | |||||||||
Negative | 199 (47) | 134 (32) |
<0.0001
| 113 (37) | 77 (24) |
<0.0001
| 174 (46) | 183 (41) | NS |
Positive | 225 (53) | 283 (68) | 196 (63) | 239 (76) | 208 (54) | 269 (59) |
Pan JNK1/2 | p-JNK1/2 | Pan p38 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
ER | |||||||||
Negative | 130 (22) | 149 (28) |
0.015
| 94 (41) | 189 (23) |
<0.0001
| 221 (31) | 89 (19) |
<0.0001
|
Positive | 466 (78) | 382 (72) | 136 (59) | 633 (77) | 492 (69) | 387 (81) | |||
HER2 | |||||||||
Negative | 478 (88) | 406 (85) | 0.092 | 184 (83) | 690 (87) | NS | 594 (88) | 385 (87) | NS |
Positive | 63 (12) | 73 (15) | 37 (17) | 103 (13) | 81 (12) | 59 (13) | |||
KI67-LI | |||||||||
Low | 199 (44) | 172 (45) | NS | 58 (31) | 292 (44) |
0.001
| 594 (88) | 385 (87) | 0.058 |
High | 255 (56) | 213 (55) | 127 (69) | 368 (56) | 81 (12) | 59 (13) | |||
P53 | |||||||||
Negative | 394 (74) | 331 (69) | NS | 149 (68) | 563 (72) | NS | 460 (69) | 331 (74) | 0.060 |
Positive | 141 (26) | 149 (31) | 70 (32) | 222 (28) | 205 (31) | 113 (26) | |||
BCL2 | |||||||||
Negative | 150 (38) | 183 (48) |
0.004
| 90 (52) | 247 (41) |
0.005
| 224 (46) | 114 (34) |
0.001
|
Positive | 246 (62) | 197 (52) | 82 (48) | 368 (59) | 259 (54) | 221 (66) |
p-p38 | p–C-JUN | p-ATF2 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
ER | |||||||||
Negative | 246 (26) | 70 (18) |
0.002
| 130 (29) | 178 (22) |
0.005
| 260 (27) | 51 (15) |
0.003
|
Positive | 692 (74) | 317 (82) | 321 (71) | 645 (78) | 693 (73) | 281 (85) | |||
HER2 | |||||||||
Negative | 777 (86) | 329 (89) | NS | 371 (86.3) | 687 (86.5) | NS | 777 (85) | 299 (92) |
0.001
|
Positive | 128 (14) | 42 (11) | 59 (13.7) | 107 (13.5) | 138 (15) | 25 (8) | |||
KI67-LI | |||||||||
Low | 292 (39) | 161 (53) |
<0.0001
| 127 (35.6) | 304 (45.8) |
0.002
| 289 (38) | 144 (53) |
<0.0001
|
High | 463 (61) | 142 (47) | 230 (64.4) | 360 (54.2) | 466 (62) | 130 (47) | |||
P53 | |||||||||
Negative | 637 (70) | 267 (73) | NS | 302 (70.2) | 564 (71.5) | NS | 634 (70) | 243 (76) |
0.025
|
Positive | 269 (30) | 97 (27) | 128 (29.8) | 225 (28.5) | 277 (30) | 76 (24) | |||
BCL2 | |||||||||
Negative | 297 (43) | 99 (36) |
0.037
| 138 (43.5) | 249 (41.2) | NS | 305 (44) | 84 (34) |
0.009
|
Positive | 391 (57) | 177 (64) | 179 (56.5) | 355 (58.8) | 396 (56) | 163 (66) |
Pan ERK1/2 | N-p-ERK1/2 | C-p-ERK1/2 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
HER2 | |||||||||
Negative | 379 (89) | 407 (92) | NS | 315 (87) | 440 (93) |
0.005
| 337 (90) | 409 (91) | NS |
Positive | 46 (11) | 37 (8) | 47 (13) | 34 (7) | 38 (10) | 42 (9) | |||
KI67-LI | |||||||||
Low | 179 (50) | 190 (52) | NS | 137 (45) | 216 (55) |
0.005
| 141 (46) | 211 (55) |
0.010
|
High | 180 (50) | 174 (4.8) | 171 (55) | 175 (45) | 169 (54) | 170 (45) | |||
P53 | |||||||||
Negative | 325 (77) | 364 (82) | 0.093 | 282 (79) | 368 (79) | NS | 291 (78) | 351 (79) | NS |
Positive | 96 (23) | 81 (18) | 76 (21) | 99 (21) | 81 (22) | 92 (21) | |||
BCL2 | |||||||||
Negative | 101 (33) | 81 (23) |
0.005
| 105 (36) | 87 (25) |
0.001
| 95 (33) | 95 (27) | NS |
Positive | 206 (67) | 269 (77) | 186 (64) | 267 (75) | 191 (67) | 254 (73) |
Pan JNK1/2 | p-JNK1/2 | Pan p38 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
HER2 | |||||||||
Negative | 386 (91) | 313 (90) | NS | 115 (87) | 553 (91) | NS | 434 (92) | 328 (90) | NS |
Positive | 36 (9) | 33 (10) | 17 (13) | 57 (9) | 35 (8) | 36 (10) | |||
KI67-LI | |||||||||
Low | 185 (53) | 152 (54) | NS | 48 (44) | 265 (53) | 0.098 | 208 (53) | 158 (52) | NS |
High | 164 (47) | 127 (46) | 61 (56) | 237 (47) | 187(47) | 144 (48) | |||
P53 | |||||||||
Negative | 338 (80) | 267 (7.8) | NS | 108 (83) | 475 (78) | NS | 373 (81) | 295 (81) | NS |
Positive | 83 (20) | 76 (22) | 22 (17) | 131 (22) | 88 (19) | 69 (19) | |||
BCL2 | |||||||||
Negative | 85 (27) | 84 (31) | NS | 36 (33) | 131 (28) | NS | 105 (31) | 66 (24) | 0.057 |
Positive | 231 (73) | 186 (69) | 73 (67) | 342 (72) | 237 (69) | 211 (76) |
p-p38 | p–C-JUN | p-ATF2 | |||||||
---|---|---|---|---|---|---|---|---|---|
Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | Low N (%) | High N (%) |
p value | |
HER2 | |||||||||
Negative | 593 (88) | 283 (95) |
0.001
| 273 (89) | 563 (90) | NS | 594 (89) | 256 (94) |
0.010
|
Positive | 78 (12) | 15 (5) | 32 (11) | 59 (10) | 73 (11) | 15 (6) | |||
KI67-LI | |||||||||
Low | 264 (47) | 147 (60) |
0.001
| 113 (44) | 277 (54) |
0.011
| 256 (47) | 136 (58) |
0.003
|
High | 295 (53) | 97 (40) | 143 (56) | 237 (46) | 292 (53) | 97 (42) | |||
P53 | |||||||||
Negative | 533 (80) | 236 (79) | NS | 248 (81) | 488 (79) | NS | 523 (79) | 523 (79) | NS |
Positive | 135 (20) | 61 (21) | 58 (19) | 128 (21) | 140 (21) | 140 (21) | |||
BCL2 | |||||||||
Negative | 162 (31) | 50 (23) |
0.026
| 71 (30) | 136 (29) | NS | 153 (29) | 55 (27) | NS |
Positive | 360 (69) | 168 (77) | 163 (70) | 333 (71) | 368 (71) | 151 (73) |